SPY319.34+7.98 2.56%
DIA271.54+8.21 3.12%
IXIC9,814.08+198.27 2.06%

Aeglea BioTherapeutics Q1 EPS $(0.570) Up From $(0.590) YoY

Aeglea BioTherapeutics (NASDAQ:AGLE) reported quarterly losses of $(0.570) per share. This is a 3.39 percent increase over losses of $(0.590) per share from the same period last year.

Benzinga · 05/07/2020 12:46

Aeglea BioTherapeutics (NASDAQ:AGLE) reported quarterly losses of $(0.570) per share. This is a 3.39 percent increase over losses of $(0.590) per share from the same period last year.